Skip to content

Read how Javara and Privia Health are aligning to integrate clinical trials into the patient continuum of care. 

Insights

What’s a ‘Myocardial Infarction’?

By Chie Mushayamunda / August 28, 2019

Closing the gap in clinical research participation through addressing health literacy Do you know what myocardial infarction means? In more simple terms, it’s a heart attack. Myocardial infarction and heart attack mean the same thing, yet one is more likely to be understood by the general population than the other. Terms like myocardial infarction, hyperlipidemia…

Read More

Engaging the Next Generation of Clinical Trial Leaders

By Liz Flores / August 5, 2019

As the clinical trial industry continues to evolve and grow, so must clinical research professionals — now and in the future. At Javara, we recognize the importance of building the next generation of clinical research professionals and we’re not alone. Organizations like The Association of Clinical Research Professionals (ACRP), are leading initiatives to expand the…

Read More

On the Highway to Access: Innovation in Awareness, Education and Transportation in Clinical Research

By Chie Mushayamunda / June 12, 2019

Lack of reliable transportation has increasingly become a barrier to patients having access to and receiving consistent healthcare. In the span of a year, it costs the United States’ healthcare system more than $150 billion as a result of missed patient appointments. The burden of missing an appointment often leads to frustration and dissatisfaction when…

Read More

Navigating Clinical Trials

By Chie Mushayamunda / May 30, 2019

Harvard Business Review reports that 26% of patients who face chronic or serious conditions have a low understanding of how to navigate the healthcare system. Similar to a complex healthcare system, the clinical trial process can be overwhelming to prospective research participants.  Javara believes there is a solution, the Clinical Trial Navigator (CTN).  Historically, this…

Read More

CRAACO 2019 Recap

By Chie Mushayamunda / May 9, 2019

Clinical research as a care option was founded on the premise of integrating clinical research as part of the patient care continuum to enhance health outcomes, reduce costs, and enhance the patient and provider experience. The CRAACO Conference provides a space for individuals to learn more about why we should deploy clinical research as a…

Read More

Language Matters – Bridging the Health Literacy Gap

By Chie Mushayamunda / May 8, 2019

Nearly 90 million people in the U.S. have difficulty understanding and acting upon health information, which affects their ability to make informed healthcare decisions. Health literacy affects an array of medical decisions, from dietary choices, to major decisions like which cancer treatment plan to pursue. People everyday make decisions about their health or the health…

Read More

How Integrated Research Organizations Benefit Pharmaceutical Development

By Jennifer Byrne / December 6, 2018

It’s no secret pharmaceutical companies face a long, uphill battle to bring new drugs to market. And one of the biggest challenges is finding and engaging the right clinical trial participants. In fact, almost half of all clinical trials are delayed because of patient enrollment issues. And a staggering 94% of trials aren’t completed on…

Read More

How Integrated Research Organizations (IROs) Support Value-Based Healthcare

By Jennifer Byrne / November 29, 2018

For the past few years, value-based healthcare has been on everyone’s mind. The shift away from fee-for-service and towards value-based payment models in healthcare isn’t happening overnight, but there is a steady growth of momentum as more and more providers and health systems make the change to value.  What are the opportunities as we consider…

Read More

Aligning physician incentives for clinical research

By Jennifer Byrne / October 25, 2018

As healthcare costs continue to rise, there is much discussion around how we pay for the services and treatments we receive. Traditionally, physicians and providers have been compensated through a fee-for-service model, leading some to ask if we are getting the level of care and outcomes commensurate with ever-increasing healthcare spending. Within this fee-for-service model,…

Read More

DPharm 2018’s Impact: A Call to Innovate

By Chie Mushayamunda / October 9, 2018

DPharm 2018 was all about a community of innovators coming together to discuss their disruptive ideas that will transform the norm of clinical research and biopharma development ultimately, to the benefit of patients. It’s clear as we look throughout the world around us, the pace of innovation is accelerating. What it affects is not selective…

Read More